Improved non-viral CAR-reprogramming of human T cells using CRISPR-Cas and double-stranded DNA

被引：0
|
作者：
Kath, J. [1 ,2 ,3 ]
Du, W. [1 ,2 ,3 ]
Glaser, V. [1 ,2 ]
Thommandru, B. [4 ]
Turk, R. [4 ]
Stein, M. [1 ,2 ]
Zittel, T. [1 ,2 ]
Woodley, J. [4 ]
Schubert, M. [4 ]
Volk, H. D. [1 ,2 ,3 ]
Schmueck-Henneresse, M. [1 ,2 ,3 ]
Jacobi, A. [4 ]
Reinke, P. [1 ,2 ,3 ]
Wagner, D. L. [1 ,2 ,3 ]
机构：
[1] Charite, Berlin, Germany
[2] Berlin Ctr Adv Therapies BeCAT, Berlin, Germany
[3] Berlin Inst Hlth, Ctr Regenerat Therapies, Berlin, Germany
[4] Integrated DNA Technol Inc, Coralville, IA USA
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR06
引用
收藏
页码：A4 / A4
页数：1
相关论文
共 44 条
  • [1] Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells
    Molaei, Zahra
    Jabbarpour, Zahra
    Omidkhoda, Azadeh
    Ahmadbeigi, Naser
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [2] Non-Viral Generation of Chimeric Antigen Receptor T Cells Using CRISPR-Cas9
    Piscopo, Nicole J.
    Mueller, Katherine P.
    Das, Amritava
    Saraspe, Louise
    Forsberg, Matthew
    Capitini, Christian
    Saha, Krishanu
    MOLECULAR THERAPY, 2020, 28 (04) : 145 - 146
  • [3] Viral and Non-Viral Delivery of the CRISPR-Cas9 System in Human Hematopoietic Stem and Progenitor Cells
    Lattanzi, Annalisa
    Meneghini, Vasco
    Pavani, Giulia
    Amor, Fatima
    Antoniani, Chiara
    Lee, Ciaran
    Porteus, Matthew
    Bao, Gang
    Amendola, Mario
    Mavilio, Fulvio
    Miccio, Annarita
    MOLECULAR THERAPY, 2017, 25 (05) : 299 - 299
  • [4] Generation of Human CAR-T Cells Using the Solupore Non-Viral Cell Engineering Platform
    Kavanagh, Heather
    Dunne, Susan
    McFadden, Emily
    O'Dea, Shirley
    MOLECULAR THERAPY, 2020, 28 (04) : 478 - 478
  • [5] Viral and non-viral delivery of the CRISPR/Cas9 system in human hematopoietic stem and progenitor cells (HSPC)
    Lattanzi, A.
    Antoniani, C.
    Lee, C.
    Pavani, G.
    Amor, F.
    Cradick, T. J.
    Lundberg, A. S.
    Porteus, M. H.
    Bao, G.
    Amendola, M.
    Mavilio, F.
    Miccio, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A140
  • [6] Probing CRISPR-Cas12a Nuclease Activity Using Double-Stranded DNA-Templated Fluorescent Substrates
    Smith, Christopher W.
    Nandu, Nidhi
    Kachwala, Mahera J.
    Chen, Yu-Sheng
    Uyar, Taha Bilal
    Yigit, Mehmet, V
    BIOCHEMISTRY, 2020, 59 (15) : 1474 - 1481
  • [7] Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
    Wagner, Dimitrios L.
    Koehl, Ulrike
    Chmielewski, Markus
    Scheid, Christoph
    Stripecke, Renata
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Non-Viral Integration of Large Cargo in Primary Human T Cells by CRISPR/Cas9 Guided Homology Mediated End Joining
    Johnson, Matthew J.
    Webber, Beau R.
    Slipek, Nicholas
    Lahr, Walker S.
    Qiu, Xiaohong
    Rathmann, Blaine
    Diers, Miechaleen D.
    Wick, Bryce
    McIvor, R. Scott
    Moriarity, Branden S.
    MOLECULAR THERAPY, 2021, 29 (04) : 1 - 2
  • [9] Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9
    Freund, Emily C.
    Lock, Jaclyn Y.
    Oh, Jaehak
    Maculins, Timurs
    Delamarre, Lelia
    Bohlen, Christopher J.
    Haley, Benjamin
    Murthy, Aditya
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (07):
  • [10] TARGETED NON-VIRAL INTEGRATION OF LARGE CARGO IN PRIMARY HUMAN T CELLS BY CRISPR/CAS9 GUIDED HOMOLOGY MEDIATED END JOINING
    Webber, Beau
    Johnson, Matthew
    Slipek, Nicholas
    Lahr, Walker
    Qiu, Xiaohong
    Rathmann, Blaine
    Diers, Miechaleen
    Wick, Bryce
    McIvor, R. Scott
    Moriarity, Branden
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A21 - A21
12345